Planning for the What Ifs – Mental Health Concerns in Advanced Parkinson’s Disease

Planning for the What Ifs, Part Two Mental Health Concerns in Advanced Parkinson’s Disease Today we continue Parkinson’s Disease: Planning for the What Ifs, a special series of posts to address both motor and non-motor issues of people with advanced Parkinson’s disease (PD). We are defining advanced PD as those who are no longer independent […]

More medications to avoid in Parkinson’s disease?

Data analysis, prescriptions trends and the risk of Parkinson’s disease It is incredibly important when taking any medication(s) to be aware of potential interactions with other drugs or supplements you may also be taking. It can be confusing, especially if you’re taking more than one medication and/or dealing with more than one ailment or disease […]

Planning for the What-Ifs — Mental health concerns in advanced PD – psychosis and behavioral problems

Planning for the What Ifs Mental Health Concerns in Advanced Parkinson’s Disease Today we continue Parkinson’s Disease: Planning for the What Ifs, a special series of posts to address both motor and non-motor issues of people with advanced Parkinson’s disease (PD). We are defining advanced PD as those who are no longer independent of their […]

Introducing a new series “Parkinson’s Disease: Planning for the What-Ifs”

Planning for Advanced Parkinson’s Disease It’s hard to think about the tough stuff. The what ifs, the worst-case scenarios, the unknowns. For most, if not all people with Parkinson’s disease (PD), the condition is progressive, which means that it gets worse with time. However, for many of you, the worsening is gradual, maybe even imperceptible […]

Repurposing medications for Parkinson’s disease

Repurposed medications to treat Parkinson’s Disease Repurposing medications is a process by which medications already approved by the Food and Drug Administration (FDA) for one reason are tested and shown to work for another purpose. One great example of this is the use of Amantadine for Parkinson’s disease (PD). Amantadine was first approved for the […]

Interview with ESPN founder Bill Rasmussen

Interview with ESPN founder Bill Rasmussen Bill Rasmussen, Founder of the sports cable network ESPN, revealed this past summer that he was diagnosed with Parkinson’s disease (PD) in 2014 at the age of 81. Since his announcement, he has been determined to spread his dual message of awareness and optimism. Recently, he sat down with […]

Why should I go to a Parkinson’s disease support group?

Why should I go to a Parkinson’s disease support group? Support groups play a vital role in the lives of many people with Parkinson’s disease (PD) and APDA plays a vital role in providing access to support groups around the country. In general terms, a support group is a collection of participants who meet on […]

Research Progress: APDA-funded research at the International Congress of Parkinson’s Disease and Movement Disorders

Research Progress: APDA-funded research at the International Congress of Parkinson’s Disease and Movement Disorders I just returned from the International Congress of Parkinson’s Disease and Movement Disorders (MDS) that took place Sept 22-Sept 26, 2019 in Nice, France. The meeting attracts scientists and clinicians from around the world who work in the field of Parkinson’s disease […]